Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2008
08/07/2008WO2008092410A1 Preparation method of thioureas or salts thereof
08/07/2008WO2008092199A1 Thiopyrimidine-based compounds and uses thereof
08/07/2008WO2008074413A3 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase
08/07/2008WO2008036642A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
08/07/2008US20080188531 Ethyl 2'-(acetylamino)-4'-methyl-4,5'-bi-1,3-thiazole-2-carboxylate; autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial, viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries
08/07/2008US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
08/07/2008US20080188472 Indole-2-Carboxylic Acid Hydrazides
08/07/2008US20080188466 Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction
08/07/2008US20080188451 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol1yl)-3-(trifluoromethyl)phenyl]benzamide or an N-oxide or salts; anticarcinogenic agent (leukaemia)
08/07/2008US20080187978 Anti-inflammatory medicaments
08/07/2008DE102007005045A1 New phenothiazine derivative for use in preparing medicine for blood sugar lowering and for treatment of diabetes, nicotine dependence, alcohol dependence, central nervous system disorders, schizophrenia, and Alzheimer's disease
08/07/2008CA2702647A1 Thiopyrimidine-based compounds and uses thereof
08/07/2008CA2677173A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
08/07/2008CA2677170A1 Polymorphic forms of a macrocyclic inhibitor of hcv
08/07/2008CA2677096A1 Kinase inhibitors
08/07/2008CA2676163A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity
08/06/2008EP1953155A2 Composition containing thiazole rings, organic semiconductor polymer containing the composition, organic active layer containing the organic semiconductor polymer, organic thin film transistor containing the organic active layer, electronic device containing the organic thin film transistor and method of preparing the same
08/06/2008EP1953147A1 Heterocyclic compound and medicinal application thereof
08/06/2008EP1951842A1 Use of rylene derivatives as photosensitizers in solar cells
08/06/2008EP1951716A1 Aminopyrimidines useful as kinase inhibitors
08/06/2008EP1951715A2 Aminopyrimidines useful as kinase inhibitors
08/06/2008EP1951707A1 Substituted pyrrolones as allosteric modulators of glucokinase
08/06/2008EP1951706A1 Dihydroisoindolones as allosteric modulators of glucokinase
08/06/2008EP1951697A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazines
08/06/2008EP1951696A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/06/2008EP1951690A1 Heterocyclic cetp inhibitors
08/06/2008EP1951678A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity
08/06/2008EP1951673A2 Heterocyclic cetp inhibitors
08/06/2008EP1951669A1 Acyl indoles, compositions containing such compounds and methods of use
08/06/2008EP1951667A2 Thrombopoietin activity modulating compounds and methods
08/06/2008EP1773768A4 Pyrrole derivatives as pharmaceutical agents
08/06/2008EP1660491B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
08/06/2008EP1648882B1 3-fluoro-piperidines as nmda/nr2b antagonists
08/06/2008CN101238120A Urea derivatives methods for their manufacture and uses thereof
08/06/2008CN101238109A Indane derivatives as modulator of ion channels
08/06/2008CN101235018A Modified method for preparing (1,4,5,6-tetrahydro-2-pyrimidyl)thiourea or salts thereof
08/06/2008CN100408573C Pyrazole compounds useful as protein kinase inhibitors
08/06/2008CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/06/2008CN100408565C Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives
08/05/2008US7408067 Neuregulins such as 4-(4-Hydroxyphenylthio)-piperidine trifluoroacetate for treatment of dysfunctions of central and autonomic nervous systems
08/05/2008US7408065 P2X7 receptor antagonists and their use
08/05/2008US7407976 Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters
08/05/2008US7407975 Epothilone derivatives, method for producing same and their pharmaceutical use
08/05/2008US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
08/05/2008US7407969 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia
08/05/2008US7407961 Adenosine antagonists; depression, dementia (e.g. Alzheimer's disease), Parkinson's disease, anxiety, pain, cerebrovascular disorders, heart failure, hypertension, edema, obesity, bronchial asthma
08/05/2008US7407960 e.g. 2-{4-[(2R)-2-hydroxy-3-(2-methylbenzothiazol-5-yloxy)propyl]piperazinyl}-N-((1S)-1-phenylethyl)acetamide; fatty acid oxidation inhibitor; cardiovascular diseases: atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's angina, stable and unstable angina, and diabetes
08/05/2008US7407950 N-(heteroaryl)-1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands
08/05/2008US7407946 Quinazoline compounds
08/05/2008CA2314514C Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents
08/05/2008CA2279319C Benzofurazan compounds which enhance ampa receptor activity
07/2008
07/31/2008WO2008091770A1 2-aminopyridine derivatives as glucokinase activators
07/31/2008WO2008091752A2 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents
07/31/2008WO2008091624A2 Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
07/31/2008WO2008091580A2 Fungicidal amides
07/31/2008WO2008091021A1 Heterocyclidene-n-(aryl)acetamide derivative
07/31/2008WO2008090757A1 Squarylium compound, squarylium compound-containing composition, optical filter and front filter for display
07/31/2008WO2008090382A1 Thiazole and oxazole derivatives for use in the treatment of prion diseases, cancer and conditions of the central nervous system as well as in the regulation of stem cells
07/31/2008WO2008090357A2 N, n; -substituted piperazines binding to melanocortin receptor
07/31/2008WO2008090048A2 3-amino-1,2-benzisothiazole compounds for combating animal pest ii
07/31/2008WO2008089892A1 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals
07/31/2008WO2008089636A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv
07/31/2008WO2008073687A3 Compounds and compositions as protein kinase inhibitors
07/31/2008WO2008061236A3 Sulfoximines as kinase inhibitors
07/31/2008WO2008060626A9 Compounds for modulating trpv3 function
07/31/2008WO2008027932A3 Cytochrome p450 oxidase inhibitors and uses thereof
07/31/2008WO2008011557A3 Heteroaryl inhibitors of rho kinase
07/31/2008WO2007077201A9 Piperazine compounds with a herbicidal action
07/31/2008US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine
07/31/2008US20080182881 TNF-alpha production inhibitors
07/31/2008US20080182880 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-]thiazolidinedione; physical form of pioglitazone; sulfonylureas, metformin, or the alpha -glucosidase inhibitors, peroxisome proliferator-activated receptor-gamma agonist; antidiabetic, hypoglycemic agent; insulin resistance
07/31/2008US20080182860 Pyrimidine Compounds as Purine Receptor Antagonist
07/31/2008US20080182854 4-Amino-5-Cyanopyrimidine Derivatives
07/31/2008US20080182850 3-(heteroaryl)alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4
07/31/2008US20080182840 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
07/31/2008US20080182798 Novel effectors of dipeptidyl peptidase IV
07/31/2008CA2676020A1 Heterocyclidene-n-(aryl) acetamide derivative
07/31/2008CA2673164A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv
07/30/2008EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
07/30/2008EP1950199A1 Proline derivatives and use thereof as drugs
07/30/2008EP1948652A1 Glucokinase activators
07/30/2008EP1948651A1 Thiazole analogues and uses thereof
07/30/2008EP1948650A1 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives useful in treatment of trpv1 related disorders
07/30/2008EP1948649A2 Fungicidal carboxamides
07/30/2008EP1948647A1 Pyrimidinyl-thiophene kinase modulators
07/30/2008EP1948645A1 Tricyclo substituted amides
07/30/2008EP1948644A1 Tricyclo substituted amides
07/30/2008EP1948627A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders
07/30/2008EP1948616A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
07/30/2008EP1948605A2 Modulators of the h3 receptor useful for the treatment of disorders related thereto
07/30/2008EP1948193A2 Aminopyrimidines useful as kinase inhibitors
07/30/2008EP1737462B1 Pyrimidines with tie2 (tek) activity
07/30/2008EP1660447B1 Cyclic amine bace-1 inhibitors having a heterocyclic substituent
07/30/2008EP1633729B1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
07/30/2008EP1041977B1 Use of ppar-gamma activators for treating dermatological disorders
07/30/2008CN101233132A Compounds for modulating TRPV3 function
07/30/2008CN101233131A Macrocyclic inhibitors of hepatitis c virus
07/30/2008CN101233128A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
07/30/2008CN101233119A Novel heterocyclic nf-kb inhibitors
07/30/2008CN101233112A Benzoquinazoline derivatives and their use in treating bone disorders